_id
6919e2173c536f8df2317f78
Ticker
0RC7.LSE
Name
Hansa Biopharma AB
Exchange
LSE
Address
ScheelevAegen 22, Lund, Sweden, 223 63
Country
UK
Sector
Industry
Currency
SEK
Website
https://www.hansabiopharma.com
Description
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Last Close
104.49552
Volume
1072
Current Price
31.86
Change
-18.943893479835307
Last Updated
2025-12-05T15:10:15.054Z
Image
https://logo.clearbit.com/www.hansabiopharma.com
Ipo Date
-
Market Cap
2945921000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
30804000
Cost Of Revenue
20108000
Gross Profit
10696000
Operating Expenses
158619000
Operating Income
-147923000
Interest Expense
10230000
Pretax Income
-147563000
Net Income
-148256000
Eps
-1.7490604592638066
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
693000
EBITDA
-137333000
Operating Margin
-480.20711595896637
Total Other Income Expense Net
360000
Cash
252072000
Short Term Investments
-
Receivables
208535000
Inventories
3529000
Total Current Assets
464136000
Property Plant Equipment
11529000
Total Assets
741105000
Payables
63604000
Short Term Debt
148229000
Long Term Debt
-
Total Liabilities
1301849000
Equity
-560744000
Depreciation
-
Change In Working Capital
17291000
Cash From Operations
-89677000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-12603000
Net Change In Cash
-102344000
PE
-
PB
-4.816023449060534
ROE
26.439159402508096
ROA
-20.00472267762328
FCF
-89677000
Fcf Percent
-2.911212829502662
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
30804000
Quarters > 0 > income Statement > cost Of Revenue
20108000
Quarters > 0 > income Statement > gross Profit
10696000
Quarters > 0 > income Statement > operating Expenses
158619000
Quarters > 0 > income Statement > operating Income
-147923000
Quarters > 0 > income Statement > interest Expense
10230000
Quarters > 0 > income Statement > pretax Income
-147563000
Quarters > 0 > income Statement > net Income
-148256000
Quarters > 0 > income Statement > eps
-1.7490604592638066
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
84763222
Quarters > 0 > income Statement > income Tax Expense
693000
Quarters > 0 > income Statement > EBITDA
-137333000
Quarters > 0 > income Statement > operating Margin
-480.20711595896637
Quarters > 0 > income Statement > total Other Income Expense Net
360000
Quarters > 0 > balance Sheet > cash
252072000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
208535000
Quarters > 0 > balance Sheet > inventories
3529000
Quarters > 0 > balance Sheet > total Current Assets
464136000
Quarters > 0 > balance Sheet > property Plant Equipment
11529000
Quarters > 0 > balance Sheet > total Assets
741105000
Quarters > 0 > balance Sheet > payables
63604000
Quarters > 0 > balance Sheet > short Term Debt
148229000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1301849000
Quarters > 0 > balance Sheet > equity
-560744000
Quarters > 0 > cash Flow > net Income
-148256000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
17291000
Quarters > 0 > cash Flow > cash From Operations
-89677000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-12603000
Quarters > 0 > cash Flow > net Change In Cash
-102344000
Quarters > 0 > ratios > PE
-1.7490604592638066
Quarters > 0 > ratios > PB
-4.816023449060534
Quarters > 0 > ratios > ROE
26.439159402508096
Quarters > 0 > ratios > ROA
-20.00472267762328
Quarters > 0 > ratios > FCF
-89677000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.911212829502662
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
49122000
Quarters > 1 > income Statement > cost Of Revenue
18266000
Quarters > 1 > income Statement > gross Profit
30856000
Quarters > 1 > income Statement > operating Expenses
185594000
Quarters > 1 > income Statement > operating Income
-154738000
Quarters > 1 > income Statement > interest Expense
13320000
Quarters > 1 > income Statement > pretax Income
-178040000
Quarters > 1 > income Statement > net Income
-178882000
Quarters > 1 > income Statement > eps
-2.526483323821699
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
70802763
Quarters > 1 > income Statement > income Tax Expense
842000
Quarters > 1 > income Statement > EBITDA
-164720000
Quarters > 1 > income Statement > operating Margin
-315.0075322666015
Quarters > 1 > income Statement > total Other Income Expense Net
-23302000
Quarters > 1 > balance Sheet > cash
354416000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
221551000
Quarters > 1 > balance Sheet > inventories
2944000
Quarters > 1 > balance Sheet > total Current Assets
578911000
Quarters > 1 > balance Sheet > property Plant Equipment
13861000
Quarters > 1 > balance Sheet > total Assets
837269000
Quarters > 1 > balance Sheet > payables
56162000
Quarters > 1 > balance Sheet > short Term Debt
149530000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1278326000
Quarters > 1 > balance Sheet > equity
-441057000
Quarters > 1 > cash Flow > net Income
-178882000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
62734000
Quarters > 1 > cash Flow > cash From Operations
-111701000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
216531000
Quarters > 1 > cash Flow > net Change In Cash
104216000
Quarters > 1 > ratios > PE
-2.526483323821699
Quarters > 1 > ratios > PB
-5.11447733326985
Quarters > 1 > ratios > ROE
40.55756965652966
Quarters > 1 > ratios > ROA
-21.364937672360973
Quarters > 1 > ratios > FCF
-111701000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.2739505720451123
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
66349000
Quarters > 2 > income Statement > cost Of Revenue
20530000
Quarters > 2 > income Statement > gross Profit
45819000
Quarters > 2 > income Statement > operating Expenses
139235000
Quarters > 2 > income Statement > operating Income
-93416000
Quarters > 2 > income Statement > interest Expense
29486000
Quarters > 2 > income Statement > pretax Income
-36738000
Quarters > 2 > income Statement > net Income
-37075000
Quarters > 2 > income Statement > eps
-0.5467140744080583
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
67814241
Quarters > 2 > income Statement > income Tax Expense
337000
Quarters > 2 > income Statement > EBITDA
-7252000
Quarters > 2 > income Statement > operating Margin
-140.7948876396027
Quarters > 2 > income Statement > total Other Income Expense Net
56678000
Quarters > 2 > balance Sheet > cash
250200000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
222390000
Quarters > 2 > balance Sheet > inventories
2890000
Quarters > 2 > balance Sheet > total Current Assets
475480000
Quarters > 2 > balance Sheet > property Plant Equipment
16193000
Quarters > 2 > balance Sheet > total Assets
705252000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
7967000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1328996000
Quarters > 2 > balance Sheet > equity
-623744000
Quarters > 2 > cash Flow > net Income
-37075000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-42148000
Quarters > 2 > cash Flow > cash From Operations
-151873000
Quarters > 2 > cash Flow > capital Expenditures
628000
Quarters > 2 > cash Flow > cash From Investing
-628000
Quarters > 2 > cash Flow > cash From Financing
-1302000
Quarters > 2 > cash Flow > net Change In Cash
-155080000
Quarters > 2 > ratios > PE
-0.5467140744080583
Quarters > 2 > ratios > PB
-3.4638597217127542
Quarters > 2 > ratios > ROE
5.943944951775087
Quarters > 2 > ratios > ROA
-5.256986155303353
Quarters > 2 > ratios > FCF
-152501000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-2.2984671961898444
Quarters > 2 > health Score
19
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
32337000
Quarters > 3 > income Statement > cost Of Revenue
13488000
Quarters > 3 > income Statement > gross Profit
18849000
Quarters > 3 > income Statement > operating Expenses
162489000
Quarters > 3 > income Statement > operating Income
-143640000
Quarters > 3 > income Statement > interest Expense
103762000
Quarters > 3 > income Statement > pretax Income
-273588000
Quarters > 3 > income Statement > net Income
-276421000
Quarters > 3 > income Statement > eps
-4.076149727901548
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
67814241
Quarters > 3 > income Statement > income Tax Expense
2833000
Quarters > 3 > income Statement > EBITDA
-169826000
Quarters > 3 > income Statement > operating Margin
-444.19704981909274
Quarters > 3 > income Statement > total Other Income Expense Net
-129948000
Quarters > 3 > balance Sheet > cash
405280000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
146333000
Quarters > 3 > balance Sheet > inventories
2610000
Quarters > 3 > balance Sheet > total Current Assets
585429000
Quarters > 3 > balance Sheet > property Plant Equipment
17880000
Quarters > 3 > balance Sheet > total Assets
800642000
Quarters > 3 > balance Sheet > payables
37622000
Quarters > 3 > balance Sheet > short Term Debt
7684000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1389957000
Quarters > 3 > balance Sheet > equity
-589315000
Quarters > 3 > cash Flow > net Income
-276421000
Quarters > 3 > cash Flow > depreciation
-26186000
Quarters > 3 > cash Flow > change In Working Capital
-52599000
Quarters > 3 > cash Flow > cash From Operations
-206838000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
57162000
Quarters > 3 > cash Flow > net Change In Cash
-148264000
Quarters > 3 > ratios > PE
-4.076149727901548
Quarters > 3 > ratios > PB
-3.6662255640192423
Quarters > 3 > ratios > ROE
46.90547500063633
Quarters > 3 > ratios > ROA
-34.524918752700955
Quarters > 3 > ratios > FCF
-206838000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.396326189813526
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
171316000
Annuals > 0 > income Statement > cost Of Revenue
83554000
Annuals > 0 > income Statement > gross Profit
87762000
Annuals > 0 > income Statement > operating Expenses
725640000
Annuals > 0 > income Statement > operating Income
-637878000
Annuals > 0 > income Statement > interest Expense
134077000
Annuals > 0 > income Statement > pretax Income
-804209000
Annuals > 0 > income Statement > net Income
-807243000
Annuals > 0 > income Statement > eps
-12.847059007765882
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
62834848
Annuals > 0 > income Statement > income Tax Expense
3034000
Annuals > 0 > income Statement > EBITDA
-642072000
Annuals > 0 > income Statement > operating Margin
-372.3400032688132
Annuals > 0 > income Statement > total Other Income Expense Net
-166331000
Annuals > 0 > balance Sheet > cash
405280000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
146333000
Annuals > 0 > balance Sheet > inventories
2610000
Annuals > 0 > balance Sheet > total Current Assets
585429000
Annuals > 0 > balance Sheet > property Plant Equipment
17880000
Annuals > 0 > balance Sheet > total Assets
800642000
Annuals > 0 > balance Sheet > payables
37622000
Annuals > 0 > balance Sheet > short Term Debt
7684000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1390475000
Annuals > 0 > balance Sheet > equity
-589833000
Annuals > 0 > cash Flow > net Income
-807243000
Annuals > 0 > cash Flow > depreciation
28060000
Annuals > 0 > cash Flow > change In Working Capital
-64027000
Annuals > 0 > cash Flow > cash From Operations
-674884000
Annuals > 0 > cash Flow > capital Expenditures
116000
Annuals > 0 > cash Flow > cash From Investing
-116000
Annuals > 0 > cash Flow > cash From Financing
346805000
Annuals > 0 > cash Flow > net Change In Cash
-326780000
Annuals > 0 > ratios > PE
-12.847059007765882
Annuals > 0 > ratios > PB
-3.4066982302149933
Annuals > 0 > ratios > ROE
136.85958567933636
Annuals > 0 > ratios > ROA
-100.82446336814705
Annuals > 0 > ratios > FCF
-675000000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.9400873240094327
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
134094000
Annuals > 1 > income Statement > cost Of Revenue
63143000
Annuals > 1 > income Statement > gross Profit
70951000
Annuals > 1 > income Statement > operating Expenses
859447000
Annuals > 1 > income Statement > operating Income
-788496000
Annuals > 1 > income Statement > interest Expense
105520000
Annuals > 1 > income Statement > pretax Income
-830812000
Annuals > 1 > income Statement > net Income
-831720000
Annuals > 1 > income Statement > eps
-15.830197775264523
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
52540089
Annuals > 1 > income Statement > income Tax Expense
908000
Annuals > 1 > income Statement > EBITDA
-714554000
Annuals > 1 > income Statement > operating Margin
-588.0173609557474
Annuals > 1 > income Statement > total Other Income Expense Net
-42316000
Annuals > 1 > balance Sheet > cash
732060000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
78025000
Annuals > 1 > balance Sheet > inventories
1513000
Annuals > 1 > balance Sheet > total Current Assets
855151000
Annuals > 1 > balance Sheet > property Plant Equipment
27073000
Annuals > 1 > balance Sheet > total Assets
1018041000
Annuals > 1 > balance Sheet > payables
86966000
Annuals > 1 > balance Sheet > short Term Debt
7503000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1185917000
Annuals > 1 > balance Sheet > equity
-167876000
Annuals > 1 > cash Flow > net Income
-831720000
Annuals > 1 > cash Flow > depreciation
19792000
Annuals > 1 > cash Flow > change In Working Capital
11436000
Annuals > 1 > cash Flow > cash From Operations
-755654000
Annuals > 1 > cash Flow > capital Expenditures
284000
Annuals > 1 > cash Flow > cash From Investing
-284000
Annuals > 1 > cash Flow > cash From Financing
-7545000
Annuals > 1 > cash Flow > net Change In Cash
-764119000
Annuals > 1 > ratios > PE
-15.830197775264523
Annuals > 1 > ratios > PB
-10.008393088429555
Annuals > 1 > ratios > ROE
495.4371083418714
Annuals > 1 > ratios > ROA
-81.69808485119951
Annuals > 1 > ratios > FCF
-755938000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-5.637373782570435
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
154525000
Annuals > 2 > income Statement > cost Of Revenue
38477000
Annuals > 2 > income Statement > gross Profit
116048000
Annuals > 2 > income Statement > operating Expenses
692168000
Annuals > 2 > income Statement > operating Income
-576120000
Annuals > 2 > income Statement > interest Expense
43666000
Annuals > 2 > income Statement > pretax Income
-609979000
Annuals > 2 > income Statement > net Income
-611134000
Annuals > 2 > income Statement > eps
-13.603731350891788
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
44923998
Annuals > 2 > income Statement > income Tax Expense
1155000
Annuals > 2 > income Statement > EBITDA
-554259000
Annuals > 2 > income Statement > operating Margin
-372.83287493933017
Annuals > 2 > income Statement > total Other Income Expense Net
-33859000
Annuals > 2 > balance Sheet > cash
1496179000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
65012000
Annuals > 2 > balance Sheet > inventories
973000
Annuals > 2 > balance Sheet > total Current Assets
1604704000
Annuals > 2 > balance Sheet > property Plant Equipment
35836000
Annuals > 2 > balance Sheet > total Assets
1687406000
Annuals > 2 > balance Sheet > payables
62476000
Annuals > 2 > balance Sheet > short Term Debt
7165000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1084494000
Annuals > 2 > balance Sheet > equity
602912000
Annuals > 2 > cash Flow > net Income
-611134000
Annuals > 2 > cash Flow > depreciation
12054000
Annuals > 2 > cash Flow > change In Working Capital
21432000
Annuals > 2 > cash Flow > cash From Operations
-502733000
Annuals > 2 > cash Flow > capital Expenditures
3331000
Annuals > 2 > cash Flow > cash From Investing
229313000
Annuals > 2 > cash Flow > cash From Financing
1117681000
Annuals > 2 > cash Flow > net Change In Cash
844837000
Annuals > 2 > ratios > PE
-13.603731350891788
Annuals > 2 > ratios > PB
2.3827947482259435
Annuals > 2 > ratios > ROE
-101.36371477097819
Annuals > 2 > ratios > ROA
-36.21736558954988
Annuals > 2 > ratios > FCF
-506064000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.2749652159844684
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
33878000
Annuals > 3 > income Statement > cost Of Revenue
15425000
Annuals > 3 > income Statement > gross Profit
18453000
Annuals > 3 > income Statement > operating Expenses
558033000
Annuals > 3 > income Statement > operating Income
-539580000
Annuals > 3 > income Statement > interest Expense
694000
Annuals > 3 > income Statement > pretax Income
-548130000
Annuals > 3 > income Statement > net Income
-548282000
Annuals > 3 > income Statement > eps
-12.328298689294458
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
44473452
Annuals > 3 > income Statement > income Tax Expense
152000
Annuals > 3 > income Statement > EBITDA
-538830000
Annuals > 3 > income Statement > operating Margin
-1592.7150363067478
Annuals > 3 > income Statement > total Other Income Expense Net
-1152000
Annuals > 3 > balance Sheet > cash
651342000
Annuals > 3 > balance Sheet > short Term Investments
237619000
Annuals > 3 > balance Sheet > receivables
11131000
Annuals > 3 > balance Sheet > inventories
242000
Annuals > 3 > balance Sheet > total Current Assets
942342000
Annuals > 3 > balance Sheet > property Plant Equipment
45784000
Annuals > 3 > balance Sheet > total Assets
1012808000
Annuals > 3 > balance Sheet > payables
53360000
Annuals > 3 > balance Sheet > short Term Debt
6888000
Annuals > 3 > balance Sheet > long Term Debt
722000
Annuals > 3 > balance Sheet > total Liabilities
255235000
Annuals > 3 > balance Sheet > equity
757573000
Annuals > 3 > cash Flow > net Income
-548282000
Annuals > 3 > cash Flow > depreciation
8606000
Annuals > 3 > cash Flow > change In Working Capital
2887000
Annuals > 3 > cash Flow > cash From Operations
-481168000
Annuals > 3 > cash Flow > capital Expenditures
2399000
Annuals > 3 > cash Flow > cash From Investing
-2399000
Annuals > 3 > cash Flow > cash From Financing
-4857000
Annuals > 3 > cash Flow > net Change In Cash
-488020000
Annuals > 3 > ratios > PE
-12.328298689294458
Annuals > 3 > ratios > PB
1.877320900847311
Annuals > 3 > ratios > ROE
-72.37348743949428
Annuals > 3 > ratios > ROA
-54.134840957022455
Annuals > 3 > ratios > FCF
-483567000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-14.27377649211878
Annuals > 3 > health Score
34
Valuation > metrics > PE
-1.7490604592638066
Valuation > metrics > PB
-4.816023449060534
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
26.439159402508096
Profitability > metrics > ROA
-31.94236172156437
Profitability > metrics > Net Margin
-4.812881443968315
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-14.459726295210166
Risk > final Score
-28
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.191046720765886
Liquidity > metrics > Quick Ratio
2.1743873711839043
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
12
Prev Profitabilities > 2
40
Prev Risks > 0
-16
Prev Risks > 1
17
Prev Risks > 2
24
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:58:44.480Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-22
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-05
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-1.76
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-30
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.7491
Earnings History > 2 > eps Estimate
-1.85
Earnings History > 2 > eps Difference
0.1009
Earnings History > 2 > surprise Percent
5.4541
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-17
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-2.5265
Earnings History > 3 > eps Estimate
-1.65
Earnings History > 3 > eps Difference
-0.8765
Earnings History > 3 > surprise Percent
-53.1212
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-04-24
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.5467
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-06
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-4.0762
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-17
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.5306
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-18
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-3.3044
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-18
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-4.1498
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-04
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-2.3629
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-09-30
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-4.7795
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-4.7895
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-3.917
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2022-12-31
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-3.1891
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-09-30
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-3.4527
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-06-30
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-3.8226
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-3.1128
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2021-12-31
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-3.6738
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-09-30
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-3.3361
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-06-30
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-2.9814
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-2.3368
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2020-12-31
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-2.3796
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-2.7735
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-2.4795
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-2.3327
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-2.7696
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-09-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-2.3551
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-06-30
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-2.059
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2019-03-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2019-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-1.8118
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-12-31
Earnings History > 29 > report Date
2018-12-31
Earnings History > 29 > date
2018-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-2.0746
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-09-30
Earnings History > 30 > report Date
2018-09-30
Earnings History > 30 > date
2018-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-1.612
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-06-30
Earnings History > 31 > report Date
2018-06-30
Earnings History > 31 > date
2018-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-1.5521
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2018-03-31
Earnings History > 32 > report Date
2018-03-31
Earnings History > 32 > date
2018-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
-1.2283
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-12-31
Earnings History > 33 > report Date
2017-12-31
Earnings History > 33 > date
2017-12-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
-
Earnings History > 33 > eps Actual
-1.3552
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-09-30
Earnings History > 34 > report Date
2017-09-30
Earnings History > 34 > date
2017-09-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
-
Earnings History > 34 > eps Actual
-1.0705
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2017-06-30
Earnings History > 35 > report Date
2017-06-30
Earnings History > 35 > date
2017-06-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
-
Earnings History > 35 > eps Actual
-1.288
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2017-03-31
Earnings History > 36 > report Date
2017-03-31
Earnings History > 36 > date
2017-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
-
Earnings History > 36 > eps Actual
-1.2835
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-12-31
Earnings History > 37 > report Date
2016-12-31
Earnings History > 37 > date
2016-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
-
Earnings History > 37 > eps Actual
-0.9978
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-09-30
Earnings History > 38 > report Date
2016-09-30
Earnings History > 38 > date
2016-09-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
-
Earnings History > 38 > eps Actual
-0.8307
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-06-30
Earnings History > 39 > report Date
2016-06-30
Earnings History > 39 > date
2016-06-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
-
Earnings History > 39 > eps Actual
-0.9463
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Stock Price
SEK0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Hansa Biopharma AB
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-1.76
Date
2025-09-30
EPS Actual
-1.7491
EPS Estimate
-1.85
EPS Difference
0.1009
Surprise Percent
5.4541%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
SEK 0
Cost Of Revenue
SEK 0
Gross Profit
SEK 0
Operating Expenses
SEK 0
Operating Income
SEK 0
Interest Expense
SEK 0
Pretax Income
SEK 0
Net Income
SEK 0
Income Tax Expense
SEK 0
EBITDA
SEK 0
Total Other Income Expense Net
SEK 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
SEK 0
Short Term Investments
SEK 0
Receivables
SEK 0
Inventories
SEK 0
Total Current Assets
SEK 0
Property Plant Equipment
SEK 0
Total Assets
SEK 0
Payables
SEK 0
Short Term Debt
SEK 0
Long Term Debt
SEK 0
Total Liabilities
SEK 0
Equity
SEK 0
(Last Updated 2025-09-30)
Net Income
SEK 0
Depreciation
SEK 0
Change In Working Capital
SEK 0
Cash From Operations
SEK 0
Capital Expenditures
SEK 0
Cash From Investing
SEK 0
Cash From Financing
SEK 0
Net Change In Cash
SEK 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.